Flavia R. Machado
Advanced in COVID-19

Flavia R. Machado

Infectious Disease
Sao Paulo, SP, BR 
Advanced in COVID-19
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Flavia Machado is an Infectious Disease expert in Sao Paulo, Brazil. Ms. Machado is rated as an Advanced expert by MediFind in the treatment of COVID-19. Her top areas of expertise are Sepsis, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Pneumonia.

Her clinical research consists of co-authoring 208 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 26 articles and participated in 2 clinical trials in the study of COVID-19.

Specialties
Infectious Disease
Gender
Female

Locations

Sao Paulo, SP, Brazil
Other Locations
Paulo, MA, Brazil
Porto Alegre, RS, Brazil
Florianopolis, SC, Brazil
Americano, PA, Brazil
Americano, SP, Brazil
Vila Da Saude, SP, Brazil
Barros, SP 04024900, Brazil
Brasileira, PI, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)
COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)
Enrollment Status: Terminated
Publish Date: August 07, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

208 Total Publications

Institutional Risk Factors Associated With Healthcare-Associated Infections in Brazilian ICUs: A Nested Cohort Within the IMPACTO-MR Platform.
Institutional Risk Factors Associated With Healthcare-Associated Infections in Brazilian ICUs: A Nested Cohort Within the IMPACTO-MR Platform.
Journal: Critical care medicine
Published: September 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Machado's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile